| 1 | Tertiary Care Virtual Online Consultation Between Doctor And Patient | 2023 |  |
| 2 | Nasojejunal Tube in Upper Gastrointestinal Conditions | 2023 | |
| 3 | Bio-Electrical Impedance Analysis For The Assessment Of Sarcopenia In Elderly | 2023 | |
| 4 | Human Skin Allograft | 2023 | |
| 5 | Negative Pressure Wound Therapy | 2023 | |
| 6 | Light Emmiting Diode Fluorescent Microscope Indetecting Mycobacterium Leprae | 2022 | |
| 7 | Mobile C-Arm Fluoroscopy for Cardiothoracic Surgery | 2022 | |
| 8 | 5-Aminolevulinic Acid (5-Ala) For Brain Tumour Surgical Procedure | 2022 | |
| 9 | Platelet Rich Plasma (PRP), Platelet-Rich Fibrin (PRF) and Concentrated Growth Factor (CGF) for Periodontal Therapy | 2022 | |
| 10 | Proton Beam Therapy For The Treatment Of Cancer – Update | 2022 | |
| 11 | Custodiol HTK as a replacement of blood cardioplegia in cardiac surgery | 2022 | |
| 12 | Therapeutic Drug Monitoring (TDM) for Anti-Tuberculosis | 2022 | |
| 13 | Robotic Arm-Assisted Surgery In Total Hip Arthroplasty | 2022 | |
| 14 | Digital Assisted oral & cranio- maxillofacial surgery | 2022 | |
| 15 | Driving Simulator in Healthcare | 2022 | |
| 16 | First Line Targeted Therapy for Advanced Hepatocellular Carcinoma (aHCC) | 2022 | |
| 17 | Artificial Intelligence Based Chest X-Ray For Lung Cancer Screening | 2022 | |
| 18 | Mesenchymal Stem Cells For Retinitis Pigmentosa And Other Degenerative Retina Disease | 2022 | |
| 19 | Intra-articular Injection of Hyaluronic Acid combined with Sorbitol / Mannitol for Osteoarthritis | 2022 | |
| 20 | Versajet Hydrosurgery System For Wound Debridement : An Update (Executive Summary Dan Full Report) | 2022 | |
| 21 | Viscoelastic haemostatic assay for non-cardiac surgery | 2022 | |
| 22 | Transcutaneous Oxygen Pressure Monitoring (TcPO2) | 2022 | |
| 23 | Virtual Reality (VR) Treatment for Amblyopia (Lazy Eyes) | 2022 | |
| 24 | Rezūm Therapy for Management of Benign Prostatic Hyperplasia | 2021 | |
| 25 | Targeted Therapies In Combination With Hormonal Therapy As A First-Line Treatment For HR Positive And HER2 Negative Metastatic Breast Cancer | 2021 | |
.png)
